Background
==========

Introduction
------------

In the eukaryotic cells, many essential biological processes take place in the nucleus. Nuclear localization is a complicated set of processes that play a crucial role in the dynamical self-regulation of the cell \[[@B1]\]. To participate in the cell regulation processes, proteins are translocated in and out of nucleus. This import and export are mediated by short binding sites on the protein sequence, called *nuclear localization signals*(NLSs) and *nuclear export signals*(NESs). Both NLSs and NESs have been used as important features to detect nuclear proteins. However, due to a tremendous amount of protein sequences generated from the post-genomic era, NLSs and NESs are not yet well understood from existing experiments by the biologists, and so the set of currently known NLSs and NESs may be incomplete. Therefore, developing computational methods to identify potential NLSs and NESs has become highly desirable to predict nuclear localization.

Previous works
--------------

At present, only a few predictors are designed specifically to identify proteins imported into the nucleus. PredictNLS \[[@B2]\] predicts nuclear proteins based on the presence of known or putative NLSs derived from the contents of NLSdb. NucPred \[[@B3]\] uses regular expression matching and multiple program classifiers induced by genetic programming to detect putative NLSs. NUCLEO \[[@B4]\] incorporates sequence motifs from known NLSs in a support vector machine (SVM) classifier for predicting nuclear localization. NpPred \[[@B5]\] applies SVM classifiers and hidden Markov models (HMM) using *k*-peptide composition and achieves high accuracy based on a data set, in which proteins are filtered at 90% sequence identity \[[@B6]\]. Although general localization prediction methods provide comprehensive information, they do not consider compartment-specific features to optimize for a particular localization site \[[@B5]\]. Besides the above predictors designed to predict nuclear localization proteins, several methods, such as NLStradamus, NetNES, and NoD, have been proposed to detect NLSs and NESs. NLStradamus \[[@B7]\] uses HMMs to predict NLSs in proteins, and NetNES \[[@B8]\] predicts NESs using neural network and HMMs. In addition, NoD \[[@B9]\] applies artificial neural network algorithm to detect nucleolar localization sequences in eukaryotic and viral proteins. Moreover, several methods \[[@B10]-[@B13]\] have been developed to further classify nuclear proteins according to their subnuclear localizations. In this study, we will propose a method to improve nuclear localization prediction based on potential NLSs and NESs generated from our analysis of gapped-dipeptide signatures.

Challenges
----------

Prediction of nuclear proteins presents several challenges. First, methods that integrate biological features only from known or putative NLSs could suffer from the problem of low coverage in high-throughput proteomic analyses due to the lack of information to characterize NESs from nuclear exported proteins. Second, several predictors are implemented on redundant training sets, which might lead to overestimation of the predictive performance. Thus, the performance would be significantly lower if redundant sequences were meticulously removed (e.g., at 25% sequence identity or even less) \[[@B4]\]. Meanwhile, the performance of amino acid composition-based and sequence homology-based methods might be significantly degraded if homologous sequences are not detected \[[@B14]\]. In addition, the *k*-peptide feature representation from amino acid composition-based methods can result in a very large feature dimension during the machine learning procedure, in which an effective feature reduction is highly desirable to reduce dimension. Finally, results of these two types of methods are generally difficult to interpret; therefore, it is difficult to determine which biological features should be used to identify nuclear or non-nuclear proteins and why they work well for prediction. If the features were biologically interpretable, the resultant knowledge could help in designing artificial proteins with the desired properties.

Our contributions
-----------------

In this study, we first present a method, PSLNuc ([P]{.ul}rotein [S]{.ul}ubcellular [L]{.ul}ocalization prediction for [Nuc]{.ul}leus), for predicting nuclear localization in proteins. For feature representation, sequence homology information from a smoothed position-specific scoring matrix (PSSM) is incorporated to calculate the weights of gapped-dipeptides. After that, probabilistic latent semantic indexing (PLSI) is used for feature reduction. Finally, the reduced features are applied as input vectors for an SVM classifier. In addition to PSLNuc, we further generate gapped-dipeptide signatures for potential NLSs and NESs, and develop another prediction method, PSLNTS ([P]{.ul}rotein [S]{.ul}ubcellular [L]{.ul}ocalization prediction using [N]{.ul}uclear [T]{.ul}ranslocation [S]{.ul}ignals). To propose candidate sequence patterns of putative NLSs and NESs, we apply PLSI to generate gapped-dipeptide signatures from both nuclear and non-nuclear proteins. Then, we further incorporate only the proposed gapped-dipeptide signatures in an SVM classifier to mimic biological properties of NLSs and NESs in PSLNTS.

Experiment results show that PSLNuc achieves high prediction accuracy, which demonstrates that homology information of gapped-dipeptides reduced by PLSI can significantly enhance the performance. Our analysis suggests that, in addition to NLSs, which have been shown important for nuclear proteins, NESs could also be an effective indicator to detect non-nuclear proteins. Most notably, the overall accuracy of PSLNTS is further improved to 0.809 using only the proposed gapped-dipeptide signatures. This implies that gapped-dipeptide signatures can better discriminate nuclear and non-nuclear localization. In addition, since sequence redundancy tends to overestimate the predictive performance, we incorporate non-redundant data sets and show the general accuracy of nuclear prediction should be approximately 0.800. Finally, since the proposed gapped-dipeptide signatures are biologically interpretable, they can be easily applied to advanced analyses and experimental designs of nuclear translocation signals.

Results and discussion
======================

Data sets
---------

To compare the predictive performance with other approaches, we utilize two benchmark data sets of proteins from Swiss-Prot that have been constructed in previous works \[[@B2]-[@B4]\]. The training and testing sets are comprised of proteins whose localization sites are experimentally determined. In addition, both the nuclear and non-nuclear proteins are redundancy-reduced using BlastClust with a 10% identity threshold, so that the remaining sequences have no more than 10% identical residues in the aligned regions covering at least 90% of the sequences. Table [1](#T1){ref-type="table"} lists the number of nuclear and non-nuclear proteins in the training and testing data sets. The training and testing sets are available in the supplementary material \[see Additional file [1](#S1){ref-type="supplementary-material"}\].

###### 

Data sets

             Nuclear   Non-nuclear
  ---------- --------- -------------
  Training   2,842     2,606
  Testing    564       398
                       
  Total      3,406     3,004

Numbers of nuclear and non-nuclear proteins for training and testing.

Predictive performance on benchmark data sets
---------------------------------------------

Table [2](#T2){ref-type="table"} shows the performance comparison with other approaches based on two benchmark data sets, a training set and an independent test set. First, evaluated by a five-fold cross-validation on the training set, PSLNuc attains an overall accuracy of 0.797, which is a 4.8% (0.048) improvement over the state-of-the-art performance by NUCLEO. In addition, our method also enhances the Matthew\'s correlation coefficient (*MCC*) from 0.497 to 0.595. Secondly, an independent test data set is incorporated to compare the predictive performance of PSLNuc, NUCLEO, PredictNLS, and NucPred. For the overall accuracy, PSLNuc significantly outperforms the other approaches by 3.9% (0.039) to 19.9% (0.199). Moreover, our method performs better by 0.077 to 0.207 in terms of *MCC*. Experiment results demonstrate that feature reduction by PLSI is able to extract discriminative features for predicting nuclear localization. Meanwhile, our method suggests that proposed smoothed PSSM (smoothPSSM) weighting scheme can better discriminate nuclear and non-nuclear localization by the incorporation of neighboring residues. Finally, in addition to NLSs, which have been shown important for nuclear proteins, NESs could also be an effective indicator to detect non-nuclear proteins.

###### 

Performance comparison

  Training Data Set (by five-fold cross-validation)                                                                   
  --------------------------------------------------- ------- ------- ----- ----- ----------- ----------- ----------- -----------
  PSLNuc                                              2,317   2,030   576   525   **0.815**   **0.779**   **0.797**   **0.595**
  NUCLEO                                              2,157   1,924   682   685   0.759       0.760       0.749       0.497
                                                                                                                      
  Independent Test Data Set                                                                                           
                                                                                                                      
                                                      tp      tn      fp    fn    Sens        Spec        Acc         *MCC*
                                                                                                                      
  PSLNuc                                              452     258     140   112   **0.805**   **0.646**   **0.739**   **0.457**
  NUCLEO                                              430     246     152   134   0.760       0.620       0.700       0.380
  PredictNLS                                          153     369     29    411   0.270       0.930       0.540       0.250
  NucPred                                             376     233     165   188   0.670       0.590       0.630       0.250

Performance comparison of different nuclear localization predictors.

Proposed gapped-dipeptide signatures correspond well with known nuclear translocation signals
---------------------------------------------------------------------------------------------

To generate gapped-dipeptides for nuclear and non-nuclear localization, we choose ten preferred topics for nuclear and non-nuclear proteins based on localization-preference confidence, respectively. The confidence is calculated by the absolute value of nuclear localization-preference minus non-nuclear localization-preference. For every preferred topic, we select up to twenty most abundant gapped-dipeptides. Finally, the resultant gapped-dipeptide signatures for nuclear and non-nuclear proteins are listed in Table [3](#T3){ref-type="table"} and Table [4](#T4){ref-type="table"}, respectively. We compare the generated gapped-dipeptide signatures with known experimentally determined NLSs and NESs in the biological literature and databases. The signatures that have been reported as motifs for NLSs and NESs are shown in bold face in Table [3](#T3){ref-type="table"} and Table [4](#T4){ref-type="table"}, respectively. It is observed that many gapped-dipeptide signatures are motifs critical for predicting nuclear localization, especially for NLSs. Our experiment results show that the proposed method can capture biological features of nuclear and non-nuclear proteins.

###### 

Gapped-dipeptide signatures for nuclear proteins

  Gapped-dipeptide signatures for nuclear proteins                                                                                         
  -------------------------------------------------- ---------- --------- --------- ---------- ---------- ---------- ---------- ---------- ----------
  G2P                                                G11P       G8P       P11P      P5P        P3Q        P5Q        **K1K**    **K6K**    **K10K**
  **K2K**                                            **K5K**    **K0K**   **K3K**   **K4K**    E4E        E1E        E8E        E0E        P1T
  P0T                                                P6T        P10T      **G2G**   **G1G**    **G5G**    P1S        S6P        P3G        G4P
  P0G                                                Q11Q       Q10Q      Q5Q       **R13R**   **R11R**   **R10R**   **R9R**    **R12R**   **R7R**
  **R3R**                                            **R4R**    C8S       S2C       S6C        N6P        P12N       S9D        E12D       D12D
  D4D                                                D13D       S12T      S8T       S10T       **K0R**    **K2R**    **R2R**    **R0R**    **R0K**
  **R2K**                                            **K1R**    **R1K**   **R3K**   **K4R**    M3P        P12M       **R1H**    Q8R        Q2H
  H0R                                                S7Q        Q12S      S13H      S10H       S2H        H6S        S12H       P7Y        P4Y
  Y5P                                                N3N        N6N       N0N       **K1H**    **H0K**    **H6K**    **K10H**   D2S        D5S
  K8S                                                D0S        N8N       H8N       H5N        **S6L**    T4E        E13S       T6E        **S13S**
  **S10S**                                           **H0H**    **H4H**   **H1H**   **H13H**   N0E        N0K        N4K        K1N        D2T
  G6L                                                G8L        E8C       K1C       K5C        K7C        C2C        C0C        K3C        C4K
  H8C                                                H12C       H13C      H10C      D6I        D10I       D12I       A13Q       A6Q        Q9A
  Q6A                                                **S11S**   M3S       Q13T      K9T        Q1T        Q9T        N1S        S7N        N8S
  H1I                                                I0H        E12I      S2E       E11I       D6A        S3D        D8A        M13Q       M3Q
  L13S                                               L12S       V6S       S9N       **S13G**   E9S        **S3S**    N0S        S3N        H1Q
  H10Q                                               H3Q        H5Q       T7E       T8E        T12E       T9E        W13K       W11K       N11I
  I12N                                               M13D       M2D       F13D      L1H        H1L        A3H        L5H        **R0G**    A9H
  H10A                                               **P3R**    A10H                                                                       

Our method propose 183 gapped-dipeptide signatures for nuclear proteins. Signatures that have been reported as motifs for nuclear localization signals (NLSs) are shown in bold face.

###### 

Gapped-dipeptide signatures for non-nuclear proteins

  Gapped-dipeptide signatures for non-nuclear proteins                                                                                    
  ------------------------------------------------------ --------- --------- --------- --------- --------- --------- ---------- --------- ---------
  **L2L**                                                **L2F**   **F5L**   **F2L**   **M0V**   **M1V**   **V0M**   **V1M**    **V3V**   **V2V**
  A3V                                                    A8V       A12I      A6I       A4I       I2A       E11L      L11Q       Q11L      L11E
  Q5W                                                    Q13W      S7W       Q12W      I13I      **I9I**   I12I      I10I       Y6Y       Y0Y
  Y5Y                                                    Y12Y      V0N       L2N       I2Q       I2S       R11A      R8A        R1A       K1L
  L1K                                                    L0K       F10A      F11A      F11S      F10S      L8A       L4A        L5A       A6L
  F3F                                                    F4F       F10F      F13F      **L8L**   **L3L**   **I3L**   **L12L**   V11D      V13D
  V7D                                                    V4D       I5E       I4D       I12E      E5I       W8P       W9P        W10P      W3P
  V5V                                                    V13V      G2V       G11V      S2S       S4S       A5S       S9S        W1H       H10W
  W8H                                                    Y10W      M3M       M2M       M13M      M0M       T0T       T13T       T7T       T1T
  H1Y                                                    H3Y       H13Y      H7Y       F12C      F9C       F0C       F10C       A7K       A3K
  A10A                                                   A4A       A5A       A9A       Y2G       Y0G       G0Y       G0F        F2K       K0F
  K3F                                                    Q13L      L13Q      L1T       L10Q      C12I      I12C      C10I       C3I       W4E
  W0L                                                    W5L       W1L       Y7T       Y7V       Y6V       V5Y       E1M        L9K       R11M
  I10K                                                   I13K      F13K      T1K       K5I       K2V       H10L      L12H       H8L       E13L
  E13I                                                   E10V      N13L      K13N      K12N      I9N       V10N      V12N       V1N       R10Q
  D3R                                                    R2D       V7G       M11G      V13G      L3G       I6N       I5N        V9I       I11N
  K7L                                                    V4H       H12V      V8H       H4V       F9E       D13L      D12L       L3D       D9L
  H11M                                                   L10M      M7H       H12I      E9L       E11A      E12A      A5E        E10A      I4N
  N0I                                                    N13I      N9I                                                                    

Our method propose 183 gapped-dipeptide signatures for non-nuclear proteins. Signatures that have been reported as motifs for nuclear export signals (NESs) are shown in bold face.

Figure [1(A](#F1){ref-type="fig"}) and [1(B](#F1){ref-type="fig"}) illustrate further analyses of amino acid composition and grouped amino acid composition of selected gapped-dipeptide signatures, respectively. When analyzing physicochemical properties in grouped amino acid composition, each amino acid is grouped into one of the four categories: aromatic (FYW), charged (DEHKR), nonpolar (AIGLMV), and polar (CNPQST). From Figure [1(A](#F1){ref-type="fig"}), it is observed that nuclear signatures show great preferences for Arginine (R), Histidine (H), and Lysine (K), which can be discovered in most NLSs; while non-nuclear signatures exhibit high compositions in Leucine (L), Isoleucine (I), Phenylalanine (F), Valine (V), Methionine (M), and Proline (P), which occur frequently in NESs. In addition, as shown in Figure [1(B](#F1){ref-type="fig"}), nuclear signatures prefer basic (HKR) or polar (CGNQSTY) amino acids, and non-nuclear ones favor hydrophobic (AFILMPVW) amino acids. Experiment results demonstrate that the amino acid preferences of selected nuclear and non-nuclear signatures correspond well with biological knowledge \[[@B15]\].

![**Physicochemical analyses of gapped-dipeptide signatures**. (A) Amino acid compositions and (B) grouped amino acid compositions of gapped-dipeptide signatures for nuclear and non-nuclear proteins.](1471-2105-13-S17-S13-1){#F1}

Gapped-dipeptide signatures better discriminate nuclear and non-nuclear proteins
--------------------------------------------------------------------------------

To demonstrate that our method can capture biological properties of putative NLSs and NESs, we further examine the predictive performance using only the proposed gapped-dipeptide signatures. In PSLNTS, we incorporate 366 selected gapped-dipeptide signatures in an SVM classifier to see whether gapped-dipeptide signatures can better discriminate nuclear and non-nuclear proteins. Table [5](#T5){ref-type="table"} compares the performance of PSLNTS, PSLNuc, and NUCLEO. Using only the 366 gapped-dipeptide signatures, PSLNTS performs slightly better than PSLNuc by nearly 0.010 (1%) and 0.023 for overall accuracy and *MCC*, respectively. Experiment results demonstrate that the selected signatures can capture biological properties of NLSs and NESs, and thus, can resolve the ambiguity to discriminate nuclear and non-nuclear proteins.

###### 

Performance comparison using gapped-dipeptide signatures

           Training Set (by five-fold cross-validation)                                                           
  -------- ---------------------------------------------- ------- ----- ----- ----------- ----------- ----------- -----------
  PSLNTS   2,429                                          1,978   628   413   **0.855**   **0.759**   **0.809**   **0.618**
  PSLNuc   2,413                                          1,964   642   429   0.815       0.779       0.797       0.595
  NUCLEO   2,157                                          1,924   682   685   0.759       0.760       0.749       0.497

Performance comparison of PSLNuc, PSLNTS, and NUCLEO.

Conclusions
===========

In this study, we first incorporate gapped-dipeptides weighted by a smoothPSSM encoding and reduced by PLSI to predict nuclear localization in PSLNuc. Our results show that PSLNuc significantly improves the predictive performance compared to the state-of-the-art system. Experiment results also suggest that, in addition to NLSs, which have been shown important for nuclear proteins, NESs can also be an effective indicator to detect non-nuclear proteins. Secondly, we apply only a few proposed gapped-dipeptide signatures in PSLNTS and further enhance the accuracy and *MCC*to 0.809 and 0.618, respectively. This demonstrates that gapped-dipeptide signatures can better discriminate nuclear and non-nuclear localization. Most notably, the proposed gapped-dipeptide signatures could be biologically interpreted and used in further experiment studies of nuclear translocation sequences, including NLSs and NESs.

Methods
=======

In this study, we extend our previously proposed method for general localization site prediction \[[@B16]\] and formulate the nuclear protein prediction as a document classification problem. In our previous work, we incorporated gapped-dipeptides as feature representation and PLSI as feature reduction for predicting protein localization sites. The method was inspired by word representation and word vector reduction in the research of document classification, where a document is assigned to one or several categories according to its content. Similarly, prediction of nuclear localization can be formulated as a document classification problem, in which a protein sequence is regarded as a document\'s content and its subcellular localization classes can be treated as categories of the document. Classification of documents is often solved in steps described as follows. First, for feature representation, each document is represented by a feature vector, where each word denotes a feature and its feature value represents the weight of a word in the document. Second, due to a high-dimensional feature space of words in a document, features are further reduced to enhance prediction accuracy and prevent overestimation \[[@B17]\]. Finally, reduced features are incorporated as input vectors in machine learning approaches for predicting document categories. To calculate the weights of each word, a standard PSSM encoding was incorporated to predict general protein localization in our previous study \[[@B16]\]. However, it has been shown that a smoothPSSM encoding scheme is more effective to predict protein structure and function \[[@B18]\]. In this study, we incorporate a new smoothPSSM encoding scheme and extend our approach to predict nuclear localization for bioinformatics analysis. The task is a large-scale analysis of nuclear proteins, including prediction of nuclear localization and analyses of nuclear translocation signals. To solve these problems, we propose a prediction method in which proteins are represented by gapped-dipeptides from smoothPSSM and PLSI is incorporated for feature reduction. Next, the feature representation, feature weighting, feature reduction, system architecture, and evaluation measures are described in the following sections.

Feature representation - gapped-dipeptides as words of proteins
---------------------------------------------------------------

When proteins are considered as documents, several types of word representation have been used, such as amino acid compositions \[[@B19]\] and *k*-peptide compositions \[[@B20]\]. Specifically, a dipeptide (*k*= 2) composition can be considered as a bi-gram word representation. However, peptides with gaps cannot be represented by a *k*-peptide composition. In addition, feature vectors with high dimensions could be generated if *k*-peptide compositions are used to represent remote sequence information. For instance, the dimension of a feature vector reaches up to 8,000 if a tri-peptide composition is considered. To distinguish nuclear and non-nuclear proteins, we incorporate gapped-dipeptide representation used in our previous work \[[@B16]\] to represent sequence features in proteins. A gapped-dipeptide *AdB*represents the sequence patterns that two amino acids *A*and *B*are divided by *d*residues. When we consider gapped-dipeptides up to *u*gapped distance, the feature dimension of gapped-dipeptides in a protein is the total number of probable combinations, that is 20 × 20 × (*u*+1). For instance, when *u*= 16, a feature vector of 6,400 (= 20 × 20 × 16) dimension is used to represent a protein sequence. Due to computational and time complexity, tri-peptides or other *k*-peptides are not considered in this study.

Feature weighting - homology information from position-specific scoring matrix
------------------------------------------------------------------------------

### Standard position-specific scoring matrix

As shown in Figure [2(A](#F2){ref-type="fig"}), a standard PSSM in a protein *P*of *n*amino acids is denoted as an *n*× 20 matrix, where *n*denotes the residues in protein *P*and 20 represents the twenty amino acids. The elements in the standard PSSM denote the amino acid substitution log-likelihood of different residues in the protein *P*\[[@B21]\]. We incorporate PSI-BLAST to generate homology information from PSSM. The parameters in PSI-BLAST are set to *j*= 3 (three iterations), *e*= 10^-3^, and the searched database is NCBI nr.

![**Construction of a smoothed PSSM profile**. Transformation of (A) a standard PSSM profile into (B) a smoothed PSSM profile using *w*as 7.](1471-2105-13-S17-S13-2){#F2}

### Smoothed position-specific scoring matrix

In this study, we incorporate a smoothPSSM encoding scheme, which has been shown effective for protein-RNA binding site prediction by considering the dependency or correlation among neighboring residues \[[@B18]\]. In a standard PSSM profile, the log-likelihood at each position is calculated based on an assumption that each position is independent from the others. Inspired by the consideration of adjacent pixels used in the spatial domain method from the research field of image processing, a new encoding scheme is proposed to consider the dependency among surrounding neighbors. We use a sliding window of size *w*to incorporate the homology information from upstream and downstream residues. In the construction of a smoothPSSM, each row vector of a residue *α~i~*is represented and smoothed by the summation of *w*surrounding row vectors (*V~smoothed_i~*= *V~i-(w-1)/2~*+ \... + *V~i~*+ \... + *V~i+(w-1)/2~*). For the N-terminal and C-terminal of a protein, *(w-1)/2*zero vectors are appended to the hand or tail of a smoothPSSM profile. Using the smoothPSSM encoding scheme, the feature vector of a residue *α~i~*is represented by (*V~smoothed_i-(w-1)/2~*, \..., *V~smoothed_i~*, \..., *V~smoothed_i+(w-1)/2~*). Here, we adopt gapped-distance as 13 and smoothing window sizes as 7 according to our previous studies \[[@B16],[@B18]\]. Figure [2(B](#F2){ref-type="fig"}) illustrates an example of a smoothPSSM profile. At position 9, the corresponding value of amino acid \'A\' represented by a smoothPSSM encoding is the sum of \[(-2) + (-2) + (-3) + 5 + (-2) + 3 + 0\]. The log-likelihoods in a smoothPSSM are normalized to 0\~1 based on a logistic function \[[@B22]\]:

$$f\left( x \right) = \frac{1}{1 + e^{- x}},$$

where *x*is a log-likelihood in a smoothPSSM.

### TFsmoothPSSM weighting scheme

Using smoothPSSM, a TFsmoothPSSM encoding is calculated in the following steps. For a protein sequence *P*of length *n*, a gapped-dipeptide A*d*B of *P*contains smoothPSSM elements that corresponds to sequence pattern *P~i~dP~i+d+1~*for 1≦*i*≦*n*-(*d*+1), in which *P~i~*represents the *i*th amino acid of *P*. Take a protein sequence MKGIKSKMLS as an example. The gapped-dipeptide M2I only shows one occurrence in the protein. However, the weighting of M2I can be contributed from different gapped-dipeptides of the protein in a smoothPSSM (i.e., M2I, K2K, G2S, I2K, K2M, S2L, and K2S). The word weighting of a gapped-dipeptide A*d*B in *P*is calculated by

$$W\left( {AdB,P} \right) = \sum\limits_{1 \leq i \leq n - {({d + 1})}}sf\left( {i,A} \right) \times sf\left( {i + d + 1,B} \right)$$

in which *sf*(*i, A*) represents a normalized log-likelihood in the smoothPSSM element of the *i*th row and the *A*th column. From the sample sequence, the weighting of M2I using a smoothPSSM profile is calculated as *sf*(1, M) × *sf*(4, I) + *sf*(2, M) × *sf*(5, I) + \... + *sf*(7, M) × *sf*(10, I). A protein is denoted as a feature vector consisting of gapped-dipeptides, where each gapped-dipeptide is weighted by TFsmoothPSSM encoding scheme. Finally, the feature vector is normalized to a range of 0 to 1.

Feature reduction - probabilistic latent semantic indexing
----------------------------------------------------------

### Probabilistic latent semantic indexing

Hofmann proposed PLSI based on an aspect model for feature reduction \[[@B17]\]. PLSI aims at identifying and discriminating between different contexts of word usage without the help from a thesaurus or dictionary. It can identify semantic similarities by classifying together words with identical or similar meanings. Latent topic variables t ∈ *T*= {*t*~1~, \..., *t~K~*} for co-occurrence data are incorporated to associate each observation in the aspect model. We use a latent topic variable *t*to model the weight of a word *w*in a document *d*, which is regarded as a joint probability *P*(*w, d*) between *w*and *d*. Therefore, *P*(*w, d*) is calculated by

$$P\left( {w,d} \right) = P\left( d \right)P\left( w \middle| d \right),P\left( w \middle| d \right) = \sum\limits_{t \in T}P\left( w \middle| t \right)P\left( t \middle| d \right)$$

in which *P*(*w*\|*t*) represents the conditional probability of a word *w*conditioned on a topic *t*, and *P*(*t*\|*d*) represents the weighting of a topic variable *t*in a document *d*. It is assumed that the word distribution given a topic class is conditionally independent of the document *d*, i.e., *P*(*w*\|*t, d*) = *P*(*w*\|*t*). Therefore, the original feature dimension \|*W*\| of the word vector is greatly reduced to the number of latent topic variables \|*T*\|.

### Probabilistic latent semantic indexing training and testing

We incorporate the same procedure as described in our previous work \[[@B16]\] to train and test PLSI model. First, for PLSI training, the parameters *P*(*w*\|*t*) and *P*(*t*\|*d*) are fitted by an iterative expectation-maximization algorithm, in which *P*(*t*\|*d*) is estimated in the expectation (E) step and *P*(*w*\|*t*) is recalculated in the maximization (M) step. Then, after training, the calculated probability of a word conditioned on a topic *P*(*w*\|*t*) is used to estimate the *P*(*t*\|*d\'*) for new documents *d\'*through a folding-in process \[[@B17]\] in PLSI testing.

### Feature reduction by probabilistic latent semantic indexing

The application of PLSI can not only reduce feature dimension, but also extract semantic relationships of gapped-dipeptides. During PLSI feature reduction process, gapped-dipeptides with similar meanings or preferences are grouped together in a semantic topic, and then the topic preferences to nuclear or non-nuclear localization can be identified. If we can select an appropriate topic size in feature reduction, the mappings of feature vectors from the gapped-dipeptide space to latent semantic topic space can greatly increase the learning efficiency and performance. One way to approximate the reduced feature size is based on latent semantic indexing (LSI). First, singular values of LSI are calculated and sorted in a decreasing order. After that, we select *t*as the reduced feature size of LSI if the *t*-th largest singular value is close to zero. Although PLSI is not identical to LSI, the number of singular values larger than zero is reasonably estimated by the number of the PLSI reduced dimensions. We take the reduced number of topics as 80 according to our previous study \[[@B16]\].

System architecture
-------------------

Prediction of protein nuclear localization can be regarded as a two-class classification problem. For a two-class classification problem, the SVM classifier has been demonstrated effective in classification \[[@B23]\]. Our prediction method consists of a one-versus-one SVM classifier corresponding to nuclear and non-nuclear proteins. For the SVM classifier in our system, we incorporate libsvm \[[@B23]\], where probability estimation values are shown to determine the classification confidences \[[@B24]\]. In libsvm, we use the Radial Basis Function (RBF) kernel and tune cost (*c*) and gamma (*γ*) parameters based on five-fold cross-validation. Here we propose PSLNuc for predicting nuclear proteins using smoothPSSM and PLSI. Our method applies gapped-dipeptides weighted by TFsmoothPSSM scheme to represent features of a protein. After that, the feature vectors are reduced by PLSI and incorporated as input vectors for an SVM classifier. The system architecture of PSLNuc is illustrated in Figure [3](#F3){ref-type="fig"}. For each protein, PSLNuc predicts its localization according to these steps:

![**System architecture of PSLNuc**. System architecture of PSLNuc based on support vector machines using reduced/transformed feature vectors.](1471-2105-13-S17-S13-3){#F3}

1\. Perform PSI-BLAST to calculate a standard PSSM for the protein.

2\. Construct a smoothPSSM profile based on the standard PSSM.

3\. Use gapped-dipeptides to represent the protein and incorporate TFsmoothPSSM encoding scheme to determine the weights in a feature vector.

4\. Apply PLSI to reduce the feature vector.

5\. Use the reduced feature vector as input and run the one-versus-one (nuclear and non-nuclear) SVM classifier.

Nuclear protein prediction based on proposed translocation signals
------------------------------------------------------------------

For localization-topic preference identification, we divide the training data sets into nuclear and non-nuclear proteins to examine preferred topics. The localization-topic preference of a topic is computed as the average of topic weights from the proteins in a localization site. A topic is identified as showing preference to a localization site if its localization-topic preference is larger than the other site. For nuclear localization prediction, we divide the proteins into two categories, and select 10 top preferred topics for nuclear and non-nuclear proteins according to localization-topic preference, respectively. To list gapped-dipeptides of interest, for each topic, up to 20 (depending on the number gapped-dipeptides in the topic) most frequent gapped-dipeptides are selected. After that, we incorporate only the proposed gapped-dipeptide signatures for nuclear and non-nuclear proteins for predicting nuclear localization. We apply the proposed gapped-dipeptide signatures to capture biological properties and mimic translocation mechanisms of nuclear translocation.

Evaluation measures
-------------------

For predictive performance comparison, the same evaluation measures applied in other approaches \[[@B2]-[@B5]\] are incorporated. Evaluation measures include sensitivity (*Sens*), specificity (*Spec*), accuracy (*Acc*; also known as success rate), and *MCC*defined in Equation (4), (5), (6), and (7) below:

$$Sensitivity = \frac{TP}{TP + FN}$$

$$Specificity = \frac{TN}{TN + FP}$$

$$Accuracy = \left( {TP + TN} \right)\left. /{} \right)N$$

$$MCC = \frac{TP \times TN - FP \times FN}{\sqrt{\left( {TP + FN} \right)\left( {TP + FP} \right)\left( {TN + FP} \right)\left( {TN + FN} \right)}}\mspace{500mu}$$

where *TP, TN, FP, FN*, and *N*represent the number of true positives, true negatives, false positives, false negatives, and total number of protein sequences, respectively. For an objective comparison with other approaches that use five-fold cross-validation, we also apply five-fold cross-validation to evaluate our predictive performance.
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